IDEAL PHARMA PEPTIDE GMBH IS AN INNOVATIVE EUROPEAN COMPANY

Using international experience and knowledge on the peptides, IDEAL PHARMA PEPTIDE has developed the production technology and methods of analysis for peptide complexes; it is conducting research on the effectiveness of their use, both in pure form and in peptide-based products.

Sophisticated, high-tech process of the peptide and peptide complex production implies the presence of complex biotechnological innovations and techniques, enormous scientific and laboratory facilities, it allows the company to take the leading place in a new segment of the market of peptides and commodity systems based on them.

Peptide complexes for the pharmaceutical, food and cosmetic industry for the production of sports nutrition and dietary supplements designed by Ideal Pharma Peptide GmbH were the epitome of the results of global research. Peptide complexes we offer represent high-tech raw materials ready for use in your ambitious plans. This is an opportunity to create innovative products and bring them to market.

MANUFACTURING

Foundation of the company - 1997

The company's production facilities and official branches are located in Germany, Japan, Russia and other countries.

IDEAL PHARMA PEPTIDE specializes in the development of manufacturing technologies and quality control methods for short peptides consisting of amino acid residues derived from

sea clams, Pacific oyster, scallop, sea urchins and deep sea fish.

QUALITY OF THE RAW MATERIAL

IPH peptide complexes have a guaranteed content of short peptides, confirmed by high-precision HPLC (High performance liquid chromatography) technique.

IDEAl PHARMA PEPTIDE has a permanent and deep cooperation with the German Frauhhofer Institute of Biotechnology and Fresenius, the largest European quality certification center.

All used methods for controlling IPH peptides are prescribed in world pharmacopeias such as USP (American Pharma), BP (British Pharma), EP (European Pharma) and JP (Japanese Pharma).

They have patent protection: patent in the United States of America No. 5,405,266, patent in the European Union No. 016704471, patent in the Russian Federation No. 645608, patent in the People's Republic of China No. 30507522).

Modern technologies for the production of IPH peptides completely repeat the natural processes of our body.

IPH peptides are at the service of more than fifty companies in the world - from medicine and pharmacology, to cosmetics and dietary supplements, sports and diabetic nutrition.

PATENTS AND SERTIFICATES

• United States Patent No. 5,405,266
• patent in the European Union No. 016704471
• patent in the Russian Federation No. 645608
• patent in the People's Republic of China No. 30507522

IPH peptides have all approvals and permissions for world markets, such as:

• WADA certificate (anti-doping)
• MAFFA certificate (safety),
• ORGANIC certificate (organic origin),
• HALAL certificate

Scientific Council